Edition:
United States

Genfit SA (GNFT.PA)

GNFT.PA on Paris Stock Exchange

24.76EUR
11:35am EDT
Change (% chg)

€-0.26 (-1.04%)
Prev Close
€25.02
Open
€24.96
Day's High
€25.10
Day's Low
€24.76
Volume
113,593
Avg. Vol
240,433
52-wk High
€32.98
52-wk Low
€20.11

Select another date:

Wed, Apr 11 2018

BRIEF-Genfit announces milestone for RESOLVE-IT Phase 3 Trial

* Major Milestone for the RESOLVE-IT Phase 3 Trial on the Recruitment of the Interim Analysis Cohort

BRIEF-Genfit FY Net Loss Widens To 58.6 Million Euros

* 2017: A YEAR OF VERY SIGNIFICANT REINFORCEMENT OF THE CASH POSITION (€274M AT 12.31.2017), WITH ALL PROGRAMS IN THE COMPANY'S PIPELINE MOVING FORWARD

BRIEF-Genfit: Official Launch Of NASH Pediatric Program In US

* REG-GENFIT: OFFICIAL LAUNCH OF THE NASH PEDIATRIC PROGRAM, FOLLOWING PIP AND PSP AGREEMENT BY EMA AND FDA

BRIEF-Genfit announces positive outcome of DSMB safety review

* REG-GENFIT: POSITIVE OUTCOME FROM THE 18-MONTH PRE-PLANNED SAFETY REVIEW BY THE DSMB, IN RESOLVE-IT PHASE 3 CLINICAL TRIAL WITH ELAFIBRANOR

Select another date: